Scott Gottlieb may face scrutiny over potential conflicts of interest.

Spike in drug company spending pushes federal share below 50%.

Researchers everywhere should pay more attention to how their subject is presented.

Its prospects for keeping dangerous people out are dubious at best. But would-be immigrants in science and tech will almost certainly be turned away.

Where do researchers from the seven banned nations go?

Starting March 15, the university will begin removing more than 20,000 video and audio lectures from public view as a result of a Justice Department accessibility order.

From Australia to Singapore, David Matthews and John Elmes weigh the pros and cons of likely destinations

Numerous research programs could be abolished.

Researchers are cutting short travel, ending collaborations and rethinking their US ties.

There’s this pervasive idea that science is somehow exempt from the ugly political world in which the rest of us wallow. But even a perfunctory look at the history of American science shows that this hasn’t always been the case.

President Donald Trump plans to change to slash spending on basic science by 10.5 percent in 2018.

A reinvigorated science policy committee is working to engage scientists, government officials, and the community—and you can too.

Richard Buckius returns to Purdue “confident” of continued federal support for research

Research and other domestic programs could have to shrink by 10.5%.

China gets bragging rights to two more internationally recognized researchers

Opportunities for students abound, but researchers don’t know what works best

AAAS, AGU now among official partners.

Crowd troubled by direction of Trump administration.

Trump Administration removed all open data (9GB) from the White House.

Amid anti-immigrant rhetoric, overseas applications drop by up to 30%

Hackers are building up robust systems to monitor changes to government websites. And they’re keeping track of data that's already been removed.

Lawmakers expected to pass bill requiring all grants to be in “the national interest”.

Nearly 100 founders and leaders of biotech companies express their deep concern and opposition to the executive order signed by President Donald Trump on January 27, 2017.

The Trump administration has mounted a vigorous defense of its ban on travel from seven majority-Muslim nations, saying it is necessary to prevent terrorists from entering the United States. But the ban, now blocked by a federal judge, also ensnared travelers important to the well-being of many Americans: doctors.

As United States and British legislators tighten the screws on travel and visa rules, they might be squeezing out international researchers and students. Canadian universities, meanwhile, are seeing surging interest from both groups.